Debra del Valle
Family · San Antonio, TXNPI 1639882467
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,735 of the $3,196 with a category attached, or 85.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,614 and has fallen 59.4% since, to $655 in 2025.
Across 89 payments — averaging $35.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$409
- Radius Health, Inc.$382
- Lilly USA, LLC$325
- Sumitomo Pharma America, Inc.$319
- Astellas Pharma US Inc$212
- Novartis$198
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,73586%
- Education$46114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $409 |
| Radius Health, Inc. | 15 | $382 |
| Lilly USA, LLC | 10 | $325 |
| Sumitomo Pharma America, Inc. | 6 | $319 |
| Astellas Pharma US Inc | 4 | $212 |
| Novartis | 8 | $198 |
| Axonics, Inc. | 1 | $148 |
| Amgen | 2 | $140 |
| Johnson & Johnson | 1 | $117 |
| Merck | 4 | $114 |
| Dendreon Pharmaceuticals LLC | 1 | $111 |
| Antares Pharma, Inc. | 1 | $110 |
| Daiichi Sankyo Inc. | 5 | $110 |
| Pfizer | 2 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Bristol Myers Squibb | 2 | $56 |
| Bayer | 2 | $43 |
| Medtronic | 1 | $40 |
| Karyopharm Therapeutics Inc. | 2 | $39 |
| Globus Medical | 1 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Urogen Pharma, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $15 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Exelixis Inc. | 1 | $15 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,196 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $520 |
| Tamsulosin Hcl | 20 | $131 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Febbie PhiriSan Antonio$31K
- Annette GantzSan Antonio$31K
- Renee ChisumSan Antonio$28K
- Thimios PartalasSan Antonio$27K
- David WeirDallas$959K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.